
    
      patients with metastatic or recurrent esophageal cancer have a particularly poor prognosis
      .The overall 5-year survival rate for patients with newly diagnosed esophageal cancer is
      under 10%. Metastatic esophageal carcinoma is an incurable disease and due to the lack of
      effective therapies to manage this disease,the median survival is only 6 to 8 months
      Chemotherapy which is one of the most effective treatment so far is used as part of combined
      modality therapy for locally advanced diseases or as a palliative treatment for metastatic
      diseases.Lobaplatin is the third generation of platinum.Phase â…¡clinical trials indicate that
      lobaplatin is effective for esophageal cancer, ovarian cancer, breast cancer and small cell
      lung cancer.
    
  